High upfront procedural cost, though long-term economics differ from chronic medication use and depend heavily on coverage.

Often covered by commercial plans and public payers when strict eligibility, documentation, and pre-op requirements are met.

Generally considered for patients with BMI of 40 or higher, or BMI of 35 or higher with obesity-related comorbidities. Some programs now consider patients with BMI of 30 or higher who have uncontrolled type 2 diabetes. Most insurers require three to six months of documented supervised weight-loss attempts before approving surgery.

Generally: BMI of 40 or higher, or BMI of 35 or higher with obesity-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnea. Some programs now consider BMI of 30 or higher with uncontrolled type 2 diabetes. Most insurers require three to six months of documented supervised weight-loss attempts before approval.

Compared with GLP-1 medications, sleeve gastrectomy offers larger average weight loss but is irreversible. Surgery is a one-time cost (often $15,000-$25,000 depending on location, surgeon, and coverage) versus ongoing monthly medication expense of $1,000 or more. Surgery requires one to three weeks of recovery and lifelong dietary changes. Medications can be stopped, but weight regain after discontinuation is common. For patients comparing the two paths, the surgery-versus-medication choice often comes down to weight-loss magnitude, permanence, willingness to accept surgical risk, and insurance coverage.

Average excess weight loss of 55-65% at one to two years after surgery, which translates to roughly 25-30% of total body weight. Significant improvement in type 2 diabetes, hypertension, and sleep apnea in a majority of patients. Long-term weight regain of 10-15% is common after three to five years, though most patients maintain a substantial net loss. Recovery typically involves one to three weeks before returning to most normal activities, with a diet that progresses from liquids to pureed foods to soft foods and then regular foods over four to six weeks.

Lifelong daily multivitamin and B12 supplementation are standard. A protein-forward diet targeting 60-80 grams per day is typically recommended. Follow-up labs are advised at 3, 6, and 12 months post-surgery, then annually. Additional supplementation for iron, calcium, and vitamin D may be needed based on lab results. Patients should expect ongoing dietary adjustments and regular follow-up visits indefinitely.

Sleeve gastrectomy is the most common bariatric procedure in the U.S. and the usual benchmark when comparing durable non-drug weight-loss results.

Risks include surgical complications, reflux, dehydration, strictures, leaks, and long-term nutrient issues.

reflux, nausea, vomiting, nutrient deficiencies, surgical complications

Laparoscopic bariatric surgery performed in the operating room.

Risks include surgical complications, reflux, dehydration, strictures, leaks, and long-term nutrient issues.